223 related articles for article (PubMed ID: 9587689)
1. Tamoxifen and the endometrium.
Barakat RR
Cancer Treat Res; 1998; 94():195-207. PubMed ID: 9587689
[No Abstract] [Full Text] [Related]
2. The duration of adjuvant tamoxifen therapy.
Bilimoria MM; Jordan VC
Cancer Treat Res; 1998; 94():181-93. PubMed ID: 9587688
[No Abstract] [Full Text] [Related]
3. [Uterine pathology in women with breast cancer treated with tamoxifen].
Carcangiu ML
Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
[No Abstract] [Full Text] [Related]
4. Hormone replacement therapy and nonhormonal control of menopausal symptoms in breast cancer survivors.
Cobleigh MA
Cancer Treat Res; 1998; 94():209-30. PubMed ID: 9587690
[No Abstract] [Full Text] [Related]
5. Gynecologic surveillance of women on tamoxifen: first do no harm.
Runowicz CD
J Clin Oncol; 2000 Oct; 18(20):3457-8. PubMed ID: 11032584
[No Abstract] [Full Text] [Related]
6. Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma.
Jagavkar RS; Shakespeare TP; Stevens MJ
Australas Radiol; 1998 May; 42(2):157-8. PubMed ID: 9599835
[No Abstract] [Full Text] [Related]
7. Breast cancer chemoprevention.
Mamounas EP
Hematol Oncol Clin North Am; 2000 Jun; 14(3):727-38. PubMed ID: 11203331
[No Abstract] [Full Text] [Related]
8. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
9. Gynaecological aspects of tamoxifen treatment in breast cancer patients.
Obwegeser R; Auerbach L; Kubista E
Cancer Treat Rev; 1997; 23(5-6):289-304. PubMed ID: 9465881
[No Abstract] [Full Text] [Related]
10. Should tamoxifen users be screened for endometrial lesions?
Neven P; Vergote I
Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866
[No Abstract] [Full Text] [Related]
11. [Tamoxifen and breast cancer: is everything known already?].
Marchetti P; Porzio G; Trapasso T; Baldi PL; Ficorella C
Tumori; 1998; 84(6):A1-5. PubMed ID: 10080686
[No Abstract] [Full Text] [Related]
12. Uterine neoplasms in patients treated with tamoxifen.
Silva EG; Tornos C; Malpica A; Mitchell MF
J Cell Biochem Suppl; 1995; 23():179-83. PubMed ID: 8747394
[TBL] [Abstract][Full Text] [Related]
13. The effects of tamoxifen treatment on the endometrium.
Daniel Y; Inbar M; Bar-Am A; Peyser MR; Lessing JB
Fertil Steril; 1996 Jun; 65(6):1083-9. PubMed ID: 8641477
[TBL] [Abstract][Full Text] [Related]
14. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
15. [Primary multiple neoplasm of the endometrium and adjuvant hormone therapy in patients with breast cancer].
Bakhidze EV; Maksimov SIa; Barash NIu; Berstein LM; Semiglazov VF; Sheĭko EV; Novik VI
Vopr Onkol; 1998; 44(2):170-4. PubMed ID: 9615821
[TBL] [Abstract][Full Text] [Related]
16. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of endometrial K-ras mutation in tamoxifen-treated patients with breast cancer.
Tsujioka H; Hachisuga T; Fukuoka M; Ueda T; Miyahara D; Horiuchi S; Shirota K; Yoshizato T; Emoto M; Miyamoto S; Kawarabayashi T
Int J Gynecol Cancer; 2009 Aug; 19(6):1052-6. PubMed ID: 19820367
[TBL] [Abstract][Full Text] [Related]
18. Endometrial lesions after tamoxifen therapy in breast cancer women.
Maugeri G; Nardo LG; Campione C; Nardo F
Breast J; 2001; 7(4):240-4. PubMed ID: 11678801
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen therapy--long-term results and complications.
Moore MP; Kinne DW
Adv Surg; 1996; 29():263-9. PubMed ID: 8720007
[No Abstract] [Full Text] [Related]
20. Tamoxifen and menopausal status: risks and benefits.
Sasco AJ
Lancet; 1996 Mar; 347(9003):761. PubMed ID: 8602018
[No Abstract] [Full Text] [Related]
[Next] [New Search]
